ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,178.00
1.88%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,627.17
0.86%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Apellis Pharmaceuticals Inc (APLS)

  7. Apellis Pharmaceuticals Inc (APLS) 뉴스

APLS Apellis Pharmaceuticals Inc

47.49
1.44 (3.13%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Apellis Pharmaceuticals Inc APLS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
1.44 3.13% 47.49 09:00:00
개장가 저가 고가 종가 전일 종가
46.62 46.10 47.74 47.49 46.05
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202420:00GLOBEApellis Announces 11 Oral Presentations at the Association..
26/04/202420:15GLOBEApellis Announces Pegcetacoplan MAA Review Has Been Reset to..
23/04/202420:00GLOBEApellis Pharmaceuticals to Host Conference Call on May 7,..
05/04/202405:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/04/202420:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
12/03/202405:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202420:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
09/03/202406:10EDGAR2Form 144 - Report of proposed sale of securities
08/03/202421:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
06/03/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:25EDGAR2Form 144 - Report of proposed sale of securities
02/03/202403:37EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/02/202421:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/02/202421:30EDGAR2Form 8-K - Current report
27/02/202421:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27/02/202421:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/02/202421:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20/02/202421:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
15/02/202407:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202400:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202405:46EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:43EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:28EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:27EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:22EDGAR2Form 144 - Report of proposed sale of securities
13/02/202405:19EDGAR2Form 144 - Report of proposed sale of securities
07/02/202406:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/02/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202400:50EDGAR2Form 144 - Report of proposed sale of securities
31/01/202400:04EDGAR2Form 144 - Report of proposed sale of securities
30/01/202405:22EDGAR2Form 144 - Report of proposed sale of securities
30/01/202405:21EDGAR2Form 144 - Report of proposed sale of securities
30/01/202405:21EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유